Study finds potential target for stopping immune system attacks in autoimmune diseases

Houston Methodist researchers have identified a key protein as a potential therapeutic target for stopping the body’s immune system from mistakenly attacking itself, offering new hope for treating autoimmune diseases and allergies.

Xlife Sciences AG Announces Strategic Merger Between palleos healthcare GmbH and OCT Clinical GmbH – Biotech Investments

Xlife Sciences AG / Key word(s): Alliance/Merger Xlife Sciences AG Announces Strategic Merger Between palleos healthcare GmbH and OCT Clinical GmbH 27.05.2024 / 07:00 CET/CEST

May 28, 2024

Study offers insights into the use of muscle-building supplements among adolescents, young adults in Canada

A recent study from the University of Toronto has revealed critical insights into the use of muscle-building supplements (such as whey protein and creatine) among

June 4, 2024

Astellas wins FDA orphan drug status for approved antifungal Cresemba – Pharmaceutical Technology

Share this article Cresemba is approved as an injection and capsule for the treatment of pediatric invasive aspergillosis and invasive mucormycosis. Image credit: JHVEPhoto/Shutterstock.com Following

March 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.